Saturday 17 October 2026
Export PHR’s income statement to Excel — free account
Phreesia, Inc.
PHR Healthcare Health Information Services
Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025. In the quarter to July 2026, revenue grew 10.4%, EPS grew 200.0%, free cash flow grew 43.5% and total debt rose 3,191.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
10.94
0.10
−0.91%
Follow PHR
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 5 | 4 | 4 |
| (1.87%) | 0.77% | 2.86% | 3.12% | ||
| (1.35%) | 0.44% | 1.72% | 1.98% | ||
ROIC |
(2.49%) | (0.94%) | 0.46% | 1.74% | |
Return on Tangible Assets |
(3.30%) | 1.97% | 6.77% | 8.18% | |
Average Days of Receivables |
69.55 | 117.44 | 105.54 | 96.52 | |
Free Cash Flow per Share |
0.58 | 0.91 | 1.04 | 1.09 | |
Free Cash Flow |
35.09 | 54.42 | 63.33 | 67.52 | |
Capital Expenditures |
(26.32) | (24.40) | (24.55) | (23.86) | |
| Other line items | |||||
Cash ROIC |
8.16% | 9.28% | 10.38% | 11.34% | |
Accounts Receivable Turnover |
5.80 | 4.21 | 4.54 | 4.81 | |
Accounts Payable Turnover |
13.34 | 18.03 | 21.12 | 17.58 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
15.41 | 27.18 | 27.23 | 27.08 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.35 | (1.26) | (9.85) | 2.78 | |
Research and Development Expense of Revenue |
25.95% | 25.28% | 23.81% | 22.90% | |
Selling, General and Administrative Expense of Revenue |
37.95% | 37.48% | 36.37% | 34.84% | |
Share Based Compensation of Revenue |
14.37% | 14.04% | 12.87% | 11.70% | |
Interest Coverage |
— | (0.83) | 0.37 | 1.19 | |
Operating CF/Net income |
(11.42) | 34.18 | 9.57 | 8.75 | |
Depreciation/Fixed assets |
1.39 | 1.72 | 1.87 | 2.26 | |
Capex/Depreciation |
(0.89) | (0.70) | (0.64) | (0.58) | |
Revenue per Share |
7.72 | 8.05 | 8.13 | 8.21 | |
Operating CF per Share |
1.02 | 1.32 | 1.44 | 1.48 | |
Capex per Share |
(0.44) | (0.41) | (0.40) | (0.39) | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.05 |
Columns are period end dates